These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34681886)

  • 1. Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review.
    Miao J; Gao P; Li Q; He K; Zhang L; Wang J; Huang L
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection.
    Cuestas ML; Mathet VL; Oubiña JR; Sosnik A
    Pharm Res; 2010 Jul; 27(7):1184-202. PubMed ID: 20333454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
    Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
    Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors.
    Zhang BY; Chai DP; Wu YH; Qiu LP; Zhang YY; Ye ZH; Yu XP
    Curr Drug Targets; 2019; 20(16):1636-1651. PubMed ID: 31362671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi for treating hepatitis B viral infection.
    Chen Y; Cheng G; Mahato RI
    Pharm Res; 2008 Jan; 25(1):72-86. PubMed ID: 18074201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside analogs as anti-HBV agents.
    Zhou XX; Littler E
    Curr Top Med Chem; 2006; 6(9):851-65. PubMed ID: 16787280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug targets in hepatitis B virus infection.
    Stein LL; Loomba R
    Infect Disord Drug Targets; 2009 Apr; 9(2):105-16. PubMed ID: 19275699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus therapy: What's the future holding for us?
    Manzoor S; Saalim M; Imran M; Resham S; Ashraf J
    World J Gastroenterol; 2015 Nov; 21(44):12558-75. PubMed ID: 26640332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of non-nucleoside anti-hepatitis B virus agents.
    Zhang F; Wang G
    Eur J Med Chem; 2014 Mar; 75():267-81. PubMed ID: 24549242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model.
    Du Y; Yang X; Li J; Sokolova V; Zou S; Han M; Yan H; Wey K; Lu M; Dittmer U; Yang D; Epple M; Wu J
    Acta Biomater; 2021 Oct; 133():297-307. PubMed ID: 33540061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of anti-HBV chemotherapy.
    Hong JH; Choi Y; Chun BK; Lee K; Chu CK
    Arch Pharm Res; 1998 Apr; 21(2):89-105. PubMed ID: 9875415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure.
    Asselah T; Loureiro D; Boyer N; Mansouri A
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):883-892. PubMed ID: 31609242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals.
    Glebe D; Goldmann N; Lauber C; Seitz S
    Antiviral Res; 2021 Feb; 186():104973. PubMed ID: 33166575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent Advances in Hepatitis B Virus Antivirals].
    Liu Q; Yao C; Guo X; Hu K
    Bing Du Xue Bao; 2016 Sep; 32(5):650-8. PubMed ID: 30004193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies for hepatitis B virus infection: towards a cure.
    Fanning GC; Zoulim F; Hou J; Bertoletti A
    Nat Rev Drug Discov; 2019 Nov; 18(11):827-844. PubMed ID: 31455905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus.
    Chen A; Panjaworayan T-Thienprasert N; Brown CM
    World J Gastroenterol; 2014 Jul; 20(25):7993-8004. PubMed ID: 25009369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally derived anti-hepatitis B virus agents and their mechanism of action.
    Wu YH
    World J Gastroenterol; 2016 Jan; 22(1):188-204. PubMed ID: 26755870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.